Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- Ulcerative Colitis: Next Target for CAR T-Cell Therapy? (Medpage Today)
- A Global Cascade Approach to Diagnosis and Management of Chronic Constipation (World Gastroenterology Organisation)
- Albany Gastroenterology Consultants: November 2024 Data Breach Affects Almost 58,000 Patients (The HIPAA Journal)
- World’s Top HealthTech Companies of 2025 (TIME)
- Gut Microbiome Changes Link Soft Drinks with Depression (Inside Precision Medicine)
- World’s First Fully Robotic Procedure by a Gastroenterologist Completed Using EndoQuest’s Endoluminal Surgical System in the PARADIGM Trial (GlobeNewswire)
- J&J exits Linx esophageal reflux business in some countries (MedTech Dive)
- Over half of US healthcare workers plan to switch jobs by next year, survey finds (Reuters)